维普期刊资源整合服务平台（V6.5）

68篇 您的检索式：作者名="KEYSTONE E"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-turnout necrosis factor biologicals : results from a 24-week multicentre randomised placebo-controlled trial 显示文摘	EMERY P KEYSTONE E TONY H P	2008	Ann Rheum Dis2008，67，11：	1
2	IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals:results from a 24-week multicentre randomised placebo-controlled trial显示文摘	Emery P Keystone E Tony HP	2008	Ann Rheum Dis2008，67，：	1
3	Rheumatic diseases clinics of North America显示文摘	Keystone E Wherry J Grint P	1998	Rheu Dis Clin Noth Am1998，24，3：	1
4	Golimumab 3 -year safety update: an analysis of pooled data from the longterm extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis 显示文摘	KAY J FLEISCHMANN R KEYSTONE E	2013	Ann Rheum Dis2013，16，：	1
5	IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals:results from a 24-week multicentre randomised placebo-controlled trial显示文摘	Emery P Keystone E Tony H P	2008	Ann Rheum Dis2008，67，：	1
6	Factors affecting the rupture of silicone-gel breast implants显示文摘	Peter W Keystone E Smith D	1994	Ann Plast Surg1994，32，5：	1
7	Recent concepu in the inhibition of radiograph- ieprogression with biologies 显示文摘	Keystone E	2009	Curr or'' in Rheu- matoi2009，21，3：	1
8	Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies显示文摘	Keystone E Emery P Peterfy C G	2009	Ann Rheum Dis2009，68，：	1
9	Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate显示文摘	Cohen SB Keystone E Genovese MC	2010	Ann Rheum Dis2010，69，6：	1
10	IL-]O as a therapeutic strategy in the treatment of rheumatoid arthritis 显示文摘	Keystone E Wherry J Grint P	1998	Rheum Dis Clin North Am1998，24，3：	1
11	Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients显示文摘	Ronald F van Vollenhoven Paul Emery Clifton O Bingham Edward C Keystone Roy M Fleischmann Daniel E Furst Nicola Tyson Neil Collinson Patricia B Lehane	2013	Annals of the Rheumatic Diseases2013，，9：	1
12	Prevention of joint structural damage at 1 year with rituximab in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors ( REFLEX Study) 显示文摘	Keystone E Emery P Peterfy CD	2006	Ann Rheum Dis2006，65，：	1
13	Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010显示文摘	Furst DE Keystone E C Braun J etal	2011	Ann Rheum Dis2011，70，1：	1
14	Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis : an open - label extension analysis 显示文摘	Keystone E Flelschmann R Emery P	2007	Arthritis Rheum2007，56，12：	1
15	IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologieals: results from a 24-week multicentre randomised placebo-controlled trial显示文摘	Emery P Keystone E Tony HP	2008	Ann Rheum Dis2008，67，11：	1
16	IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis显示文摘	Keystone E Wherry J Grint P	1998	Rheum Dis Clin North Am1998，24，3：	1
17	Updated Consen- sus Statement on Biological Agents for the Treatment of Rheumatic Diseases,2011显示文摘	Furst D E Keystone E C Braun J	2012	Ann Rheum Dis2012，71，12：	1
18	Infliximab in active early rheumatoidarthritis显示文摘	Breedveld FC Emery P Keystone E	2004	Ann Rheum Dis2004，63，2：	1
19	Rheumatic diseases clinics of north america 显示文摘	Keystone E Wherry J Grint P	1998	Rheu Dis Clin Noth Am1998，24，3：	1
20	Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis:ARMADA 4 year extended study显示文摘	Keystone E C Furst D E	2006	Annals of the Rheumatic Diseases2006，65，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示